-
Je něco špatně v tomto záznamu ?
Nitro-oleic acid modulates classical and regulatory activation of macrophages and their involvement in pro-fibrotic responses
G. Ambrozova, H. Martiskova, A. Koudelka, T. Ravekes, TK. Rudolph, A. Klinke, V. Rudolph, BA. Freeman, SR. Woodcock, L. Kubala, M. Pekarova,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
- MeSH
- aktivace makrofágů účinky léků MeSH
- fibróza MeSH
- interleukin-4 farmakologie MeSH
- kultivované buňky MeSH
- kyseliny olejové farmakologie MeSH
- lipopolysacharidy farmakologie MeSH
- myokard patologie MeSH
- myši inbrední C57BL MeSH
- myši MeSH
- oxid dusnatý biosyntéza MeSH
- PPAR gama fyziologie MeSH
- superoxidy metabolismus MeSH
- transkripční faktor STAT3 fyziologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
Inflammation is an immune response triggered by microbial invasion and/or tissue injury. While acute inflammation is directed toward invading pathogens and injured cells, thus enabling tissue regeneration, chronic inflammation can lead to severe pathologies and tissue dysfunction. These processes are linked with macrophage polarization into specific inflammatory "M1-like" or regulatory "M2-like" subsets. Nitro-fatty acids (NO2-FAs), produced endogenously as byproducts of metabolism and oxidative inflammatory conditions, may be useful for treating diseases associated with dysregulated immune homeostasis. The goal of this study was to characterize the role of nitro-oleic acid (OA-NO2) in regulating the functional specialization of macrophages induced by bacterial lipopolysaccharide or interleukin-4, and to reveal specific signaling mechanisms which can account for OA-NO2-dependent modulation of inflammation and fibrotic responses. Our results show that OA-NO2 inhibits lipopolysaccharide-stimulated production of both pro-inflammatory and immunoregulatory cytokines (including transforming growth factor-β) and inhibits nitric oxide and superoxide anion production. OA-NO2 also decreases interleukin-4-induced macrophage responses by inhibiting arginase-I expression and transforming growth factor-β production. These effects are mediated via downregulation of signal transducers and activators of transcription, mitogen-activated protein kinase and nuclear factor-кB signaling responses. Finally, OA-NO2 inhibits fibrotic processes in an in vivo model of angiotensin II-induced myocardial fibrosis by attenuating expression of α-smooth muscle actin, systemic transforming growth factor-β levels and infiltration of both "M1-" and "M2-like" macrophage subsets into afflicted tissue. Overall, the electrophilic fatty acid derivative OA-NO2 modulates a broad range of "M1-" and "M2-like" macrophage functions and represents a potential therapeutic approach to target diseases associated with dysregulated macrophage subsets.
Department of Animal Physiology and Immunology Masaryk University Brno Czech Republic
Department of Pharmacology and Chemical Biology University of Pittsburgh Pittsburgh PA USA
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000833
- 003
- CZ-PrNML
- 005
- 20170117092946.0
- 007
- ta
- 008
- 170103s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.freeradbiomed.2015.11.026 $2 doi
- 024 7_
- $a 10.1016/j.freeradbiomed.2015.11.026 $2 doi
- 035 __
- $a (PubMed)26620549
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Ambrozova, Gabriela $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Kralovopolska 135, 612 65 Brno, Czech Republic. $7 gn_A_00005405
- 245 10
- $a Nitro-oleic acid modulates classical and regulatory activation of macrophages and their involvement in pro-fibrotic responses / $c G. Ambrozova, H. Martiskova, A. Koudelka, T. Ravekes, TK. Rudolph, A. Klinke, V. Rudolph, BA. Freeman, SR. Woodcock, L. Kubala, M. Pekarova,
- 520 9_
- $a Inflammation is an immune response triggered by microbial invasion and/or tissue injury. While acute inflammation is directed toward invading pathogens and injured cells, thus enabling tissue regeneration, chronic inflammation can lead to severe pathologies and tissue dysfunction. These processes are linked with macrophage polarization into specific inflammatory "M1-like" or regulatory "M2-like" subsets. Nitro-fatty acids (NO2-FAs), produced endogenously as byproducts of metabolism and oxidative inflammatory conditions, may be useful for treating diseases associated with dysregulated immune homeostasis. The goal of this study was to characterize the role of nitro-oleic acid (OA-NO2) in regulating the functional specialization of macrophages induced by bacterial lipopolysaccharide or interleukin-4, and to reveal specific signaling mechanisms which can account for OA-NO2-dependent modulation of inflammation and fibrotic responses. Our results show that OA-NO2 inhibits lipopolysaccharide-stimulated production of both pro-inflammatory and immunoregulatory cytokines (including transforming growth factor-β) and inhibits nitric oxide and superoxide anion production. OA-NO2 also decreases interleukin-4-induced macrophage responses by inhibiting arginase-I expression and transforming growth factor-β production. These effects are mediated via downregulation of signal transducers and activators of transcription, mitogen-activated protein kinase and nuclear factor-кB signaling responses. Finally, OA-NO2 inhibits fibrotic processes in an in vivo model of angiotensin II-induced myocardial fibrosis by attenuating expression of α-smooth muscle actin, systemic transforming growth factor-β levels and infiltration of both "M1-" and "M2-like" macrophage subsets into afflicted tissue. Overall, the electrophilic fatty acid derivative OA-NO2 modulates a broad range of "M1-" and "M2-like" macrophage functions and represents a potential therapeutic approach to target diseases associated with dysregulated macrophage subsets.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a fibróza $7 D005355
- 650 _2
- $a interleukin-4 $x farmakologie $7 D015847
- 650 _2
- $a lipopolysacharidy $x farmakologie $7 D008070
- 650 _2
- $a aktivace makrofágů $x účinky léků $7 D008262
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a myokard $x patologie $7 D009206
- 650 _2
- $a oxid dusnatý $x biosyntéza $7 D009569
- 650 _2
- $a kyseliny olejové $x farmakologie $7 D009829
- 650 _2
- $a PPAR gama $x fyziologie $7 D047495
- 650 _2
- $a transkripční faktor STAT3 $x fyziologie $7 D050796
- 650 _2
- $a superoxidy $x metabolismus $7 D013481
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Martiskova, Hana $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Kralovopolska 135, 612 65 Brno, Czech Republic; Department of Animal Physiology and Immunology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Koudelka, Adolf $u Department of Animal Physiology and Immunology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Ravekes, Thorben $u Heart Centre, University Hospital of Cologne, Cologne, Germany.
- 700 1_
- $a Rudolph, Tanja K $u Heart Centre, University Hospital of Cologne, Cologne, Germany.
- 700 1_
- $a Klinke, Anna $u Heart Centre, University Hospital of Cologne, Cologne, Germany; International Clinical Research Center-Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Rudolph, Volker $u Heart Centre, University Hospital of Cologne, Cologne, Germany.
- 700 1_
- $a Freeman, Bruce A $u Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA.
- 700 1_
- $a Woodcock, Steven R $u Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA.
- 700 1_
- $a Kubala, Lukas $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Kralovopolska 135, 612 65 Brno, Czech Republic; International Clinical Research Center-Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Pekarova, Michaela $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Kralovopolska 135, 612 65 Brno, Czech Republic; International Clinical Research Center-Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital, Brno, Czech Republic. Electronic address: pekarovam@ibp.cz.
- 773 0_
- $w MED00001857 $t Free radical biology & medicine $x 1873-4596 $g Roč. 90, č. - (2016), s. 252-60
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26620549 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170117093053 $b ABA008
- 999 __
- $a ok $b bmc $g 1179973 $s 961400
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 90 $c - $d 252-60 $e 20151124 $i 1873-4596 $m Free radical biology & medicine $n Free Radic Biol Med $x MED00001857
- LZP __
- $a Pubmed-20170103